Nplate 250 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCE9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,054
Award facts
- Contract value 100% obligated
- $20,053.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,053.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 mcg vials. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group Inc. is the sole awardee with no identified subcontractors on this delivery order.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.99 billion strategic acquisition framework designed to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The PPV-G GEN V represents part of the broader $30.3 billion acquisition strategy and positions DMS Pharmaceutical Group as a regional prime vendor contractor. Through this IDC structure, which runs through December 31, 2036, DLA maintains flexibility to issue firm fixed-price delivery orders for the diverse pharmaceutical requirements of military medical operations globally, with DMS Pharmaceutical Group's demonstrated performance on numerous prior awards establishing its capability to fulfill specialized federal pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DR26FSCE9?
SPE2DR26FSCE9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FSCE9 worth?
The government has obligated $20,054 on SPE2DR26FSCE9.
Is contract SPE2DR26FSCE9 an order under another contract?
Yes. SPE2DR26FSCE9 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCE9 competed?
The extent of competition for SPE2DR26FSCE9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award